COMMUNIQUÉS West-GlobeNewswire

Capital Senior Living Corporation Reports Second Quarter 2018 Results
31/07/2018
DALLAS, July 31, 2018 (GLOBE NEWSWIRE) -- Capital Senior Living Corporation (the “Company”) (NYSE:CSU), one of the nation’s largest operators of senior housing communities, today announced operating and financial [...]
Precision Optics Corporation, Inc. Announces Fourth Quarter 2018 Preliminary Revenue of $1.4 - $1.5 Million
31/07/2018
GARDNER, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”), a leading developer and manufacturer of advanced micro-optical components used in next generation [...]
Pernix Therapeutics to Report Second Quarter 2018 Financial Results on Thursday, August 9
31/07/2018
MORRISTOWN, N.J., July 31, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that the Company will report financial results for the second [...]
Amedisys Reports Second Quarter 2018 Financial Results and Updates 2018 Guidance
31/07/2018
BATON ROUGE, La., July 31, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month period ended June 30, 2018. Three Month Periods Ended June 30, 2018 and [...]
Amedisys Signs Definitive Agreement to Acquire Bring Care Home
31/07/2018
BATON ROUGE, La., July 31, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ:AMED), one of the nation’s leading home healthcare, hospice and personal care companies, announced today that its subsidiary, Associated Home [...]
Geron Corporation Reports Second Quarter 2018 Financial Results and Recent Company Events
31/07/2018
Conference Call Scheduled for July 31 at 4:30 p.m. ET MENLO PARK, Calif., July 31, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN) today reported financial results for the three and six months ended June 30, [...]
AC Immune Announces Successful Closing of Second Subscription Rights Offering
31/07/2018
Gross Proceeds of All Three Offerings of 10 Million Common Shares in Total Aggregate to USD 117.5 Million Lausanne, Switzerland, July 31, 2018 - AC Immune, SA (NASDAQ: ACIU), a Swiss-based, clinical-stage [...]
Cara Therapeutics to Announce Second Quarter 2018 Financial Results on August 7, 2018
31/07/2018
STAMFORD, Conn., July 31, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a clinical-stage biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate [...]
Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)
31/07/2018
Oasmia Pharmaceutical AB (publ) (”Oasmia”) on the 29 November 2017 issued a convertible loan with a total nominal amount of MSEK 28. In total MSEK 9 of the convertible loan have during July, at the request of [...]
Cellectar Biosciences Announces Closing of $16.56 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
31/07/2018
MADISON, Wis., July 31, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of [...]
Prothena to Report Second Quarter 2018 Financial Results on August 7
31/07/2018
DUBLIN, Ireland, July 31, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six months of 2018 on [...]
Myriad Announces Closing of Counsyl Acquisition
31/07/2018
Transformational Acquisition Enhances Myriad’s Leadership Position in Women’s Health SALT LAKE CITY, July 31, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, [...]
OmniSeq, Inc. to Participate in the NCI-MATCH Clinical Trial
31/07/2018
Having Met Rigorous Qualifications, OmniSeq Becomes One of Several Commercial and Academic Laboratories Designated by the National Cancer Institute to Cast a Wider Net for Patients to Enter the NCI-MATCH Trial BUFFALO, [...]
Zafgen to Host Conference Call to Discuss Second Quarter 2018 Financial Results
31/07/2018
BOSTON, July 31, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]
Todos Medical, Ltd. Appoints Herman Weiss, MD MBA as New Chief Executive Officer
31/07/2018
REHOVOT, Israel, July 31, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) ( http://www.Todosmedical.com ) today announced that its Board of Directors has appointed Herman Weiss, MD MBA as the new Chief [...]
Nuvectra™ to Report Second Quarter 2018 Financial Results on August 7, 2018
31/07/2018
PLANO, Texas, July 31, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, announced today that it will release its financial results for the second quarter ended [...]
Vital Therapies Announces Upcoming Second Quarter Financial Results Conference Call With Webcast
31/07/2018
SAN DIEGO, July 31, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, will release its [...]
Acer Therapeutics Announces Underwritten Public Offering
31/07/2018
NEWTON, Mass., July 31, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
NewLink Genetics Announces Clinical Plan, Reports Second Quarter 2018 Financial Results and Revises Cash Guidance
31/07/2018
Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, July 31, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced its clinical plan and strategy, reported consolidated [...]

Pages